Hybrid Oncology Clinical Forums: Advanced Non-Melanoma Skin Cancer in Patients: Incorporating Advances in Immune Checkpoint Inhibitors to Optimize Outcomes

Hybrid Oncology Clinical Forums: Advanced Non-Melanoma Skin Cancer in Patients: Incorporating Advances in Immune Checkpoint Inhibitors to Optimize Outcomes

Topics Include: Improving Screening for Efficacy and Safety of Immune Checkpoint Inhibitors for Treating Advanced NMSC Safety Considerations and Managing Patients With NMSC

  • Provider:Medical Education Resources
  • Activity Link: https://mycme.com
  • Start Date: 2024-10-31 05:00:00
  • End Date: 2024-10-31 05:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
    Nursing: 1.0 hours
    Pharmacy: 1.0 hours
  • Commercial Support: Source: Regeneron Pharmaceuticals, Inc. - Amount: 120020.0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Jointly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.